Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma
dc.creator | Espinoza J.A. | |
dc.creator | Riquelme I. | |
dc.creator | Sagredo E.A. | |
dc.creator | Rosa L. | |
dc.creator | García P. | |
dc.creator | Bizama C. | |
dc.creator | Apud-Bell M. | |
dc.creator | Leal P. | |
dc.creator | Weber H. | |
dc.creator | Benavente F. | |
dc.creator | Vargas S. | |
dc.creator | Romero D. | |
dc.creator | Kalergis A.M. | |
dc.creator | Roa J.C. | |
dc.date.accessioned | 2020-09-02T22:17:19Z | |
dc.date.accessioned | 2022-11-08T20:27:33Z | |
dc.date.available | 2020-09-02T22:17:19Z | |
dc.date.available | 2022-11-08T20:27:33Z | |
dc.date.created | 2020-09-02T22:17:19Z | |
dc.date.issued | 2019 | |
dc.identifier | 74, 4, 597-607 | |
dc.identifier | 03090167 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4394 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146497 | |
dc.language | en | |
dc.publisher | Blackwell Publishing Ltd | |
dc.subject | biomarker | |
dc.subject | CA9 | |
dc.subject | CLDN18 | |
dc.subject | Gallbladder cancer | |
dc.subject | MUC5B | |
dc.subject | theranostic | |
dc.subject | carbonate dehydratase IX | |
dc.subject | claudin 18 | |
dc.subject | messenger RNA | |
dc.subject | mucin 5B | |
dc.subject | protein p53 | |
dc.subject | proteome | |
dc.subject | transcription factor Cdx2 | |
dc.subject | transcriptome | |
dc.subject | tumor marker | |
dc.subject | CA9 protein, human | |
dc.subject | carbonate dehydratase IX | |
dc.subject | claudin | |
dc.subject | CLDN18 protein, human | |
dc.subject | mucin 5B | |
dc.subject | tumor antigen | |
dc.subject | tumor marker | |
dc.subject | adult | |
dc.subject | advanced cancer | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | bile duct carcinoma | |
dc.subject | cancer growth | |
dc.subject | cancer patient | |
dc.subject | carcinogenesis | |
dc.subject | chronic cholecystitis | |
dc.subject | clinical feature | |
dc.subject | cohort analysis | |
dc.subject | dysplasia | |
dc.subject | female | |
dc.subject | gallbladder carcinoma | |
dc.subject | gallbladder epithelium | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | molecular pathology | |
dc.subject | mRNA expression level | |
dc.subject | priority journal | |
dc.subject | protein expression level | |
dc.subject | tissue microarray | |
dc.subject | biosynthesis | |
dc.subject | gallbladder tumor | |
dc.subject | middle aged | |
dc.subject | pathology | |
dc.subject | procedures | |
dc.subject | theranostic nanomedicine | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Antigens, Neoplasm | |
dc.subject | Biomarkers, Tumor | |
dc.subject | Carbonic Anhydrase IX | |
dc.subject | Claudins | |
dc.subject | Female | |
dc.subject | Gallbladder Neoplasms | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Mucin-5B | |
dc.subject | Theranostic Nanomedicine | |
dc.title | Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma | |
dc.type | Article |